Comparison of clinical outcomes of implantable collamer lens versus femtosecondlaser in situ keratomileusis and small incision lenticule extraction for moderate-to-high myopia and myopic astigmatism correction

Y. H. Tran, Huy D M Tran, L. T. Tran, D. Nguyen, C. N. Le, T. Bui
{"title":"Comparison of clinical outcomes of implantable collamer lens versus femtosecondlaser in situ keratomileusis and small incision lenticule extraction for moderate-to-high myopia and myopic astigmatism correction","authors":"Y. H. Tran, Huy D M Tran, L. T. Tran, D. Nguyen, C. N. Le, T. Bui","doi":"10.35119/ASJOO.V17I4.714","DOIUrl":null,"url":null,"abstract":"Purpose: To compare safety, efficacy, stability, and predictability of implantable collamer lens (ICL) with femtosecond-laser in situ keratomileusis (FS-LASIK) or small incision lenticule extraction (SMILE) for the correction of moderate-to-high myopia/myopic astigmatism. \nStudy design: We retrospectively collected data from patients with moderate-to-high myopia/myopic astigmatism (spherical equivalent [SE] ≥ −3.00 diopters [D]) who underwent ICL (48 eyes), FS-LASIK (36 eyes), or SMILE (86 eyes) at Hai Yen Eye Center from October 2016 to February 2018. \nMaterials and methods: The Wilcoxon Mann-Whitney U test was used to compare pre- and postoperative patients’ characteristics of ICL with SMILE or FS-LASIK. Generalized linear models with unstructured correlation matrix and robust standard errors were used to analyze efficacy and safety indices; logistic regression was used for cylinder predictability. \nResults: After controlling for age, preoperative SE, and preoperative corrected distance visual acuity (pCDVA), SMILE had significantly lower safety indices (Coefficient = −0.04, 95% CI = −0.07–−0.01) and efficacy indices (Coefficient = −0.10, 95% CI = −0.20–−0.01) than did ICL, while FS-LASIK was not significantly different from ICL (Coefficient = −0.02, 95% CI = −0.06–0.02 and Coefficient = −0.01, 95% CI= −0.10–0.09, respectively). ICL SEswere stable over 12 months after surgery. However, in FS-LASIK and SMILE, SEs significantly decreased at 12 months compared with 6 months after surgery. The percentage of eyes that underwent FS-LASIK and had target SEs within ±0.5 D at 12 months was significantly lower than those that underwent ICL (OR = 0.14, 95% CI = 0.02–0.85), after controlling for age, preoperative SE, and pCDVA. \nConclusion: For the correction of moderate-to-high myopia/myopic astigmatism, ICL seems to perform better than SMILE and FS-LASIK.","PeriodicalId":39864,"journal":{"name":"Asian Journal of Ophthalmology","volume":"17 1","pages":"400-415"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35119/ASJOO.V17I4.714","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To compare safety, efficacy, stability, and predictability of implantable collamer lens (ICL) with femtosecond-laser in situ keratomileusis (FS-LASIK) or small incision lenticule extraction (SMILE) for the correction of moderate-to-high myopia/myopic astigmatism. Study design: We retrospectively collected data from patients with moderate-to-high myopia/myopic astigmatism (spherical equivalent [SE] ≥ −3.00 diopters [D]) who underwent ICL (48 eyes), FS-LASIK (36 eyes), or SMILE (86 eyes) at Hai Yen Eye Center from October 2016 to February 2018. Materials and methods: The Wilcoxon Mann-Whitney U test was used to compare pre- and postoperative patients’ characteristics of ICL with SMILE or FS-LASIK. Generalized linear models with unstructured correlation matrix and robust standard errors were used to analyze efficacy and safety indices; logistic regression was used for cylinder predictability. Results: After controlling for age, preoperative SE, and preoperative corrected distance visual acuity (pCDVA), SMILE had significantly lower safety indices (Coefficient = −0.04, 95% CI = −0.07–−0.01) and efficacy indices (Coefficient = −0.10, 95% CI = −0.20–−0.01) than did ICL, while FS-LASIK was not significantly different from ICL (Coefficient = −0.02, 95% CI = −0.06–0.02 and Coefficient = −0.01, 95% CI= −0.10–0.09, respectively). ICL SEswere stable over 12 months after surgery. However, in FS-LASIK and SMILE, SEs significantly decreased at 12 months compared with 6 months after surgery. The percentage of eyes that underwent FS-LASIK and had target SEs within ±0.5 D at 12 months was significantly lower than those that underwent ICL (OR = 0.14, 95% CI = 0.02–0.85), after controlling for age, preoperative SE, and pCDVA. Conclusion: For the correction of moderate-to-high myopia/myopic astigmatism, ICL seems to perform better than SMILE and FS-LASIK.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
植入式晶体与飞秒激光原位角膜磨镶术及小切口晶状体摘除治疗中高度数近视和近视散光的临床效果比较
目的:比较可植入collamer晶状体(ICL)与飞秒激光原位角膜磨镶术(FS-LASIK)或小切口晶状体摘除术(SMILE)矫正中高度近视/近视散光的安全性、有效性、稳定性和可预测性。研究设计:我们回顾性收集了2016年10月至2018年2月在海燕眼科中心接受ICL(48眼)、FS-LASIK(36眼)或SMILE(86眼)治疗的中高度近视/近视散光(球面当量[SE]≥−3.00屈光度[D])患者的数据。材料和方法:采用Wilcoxon-Mann-Whitney U检验比较SMILE或FS-LASIK治疗前后ICL患者的特点。使用具有非结构化相关矩阵和稳健标准误差的广义线性模型来分析疗效和安全性指标;采用逻辑回归方法进行圆柱体预测。结果:在控制了年龄、术前SE和术前矫正远距视力(pCDVA)后,SMILE的安全性指数(系数=−0.04,95%CI=−0.07–−0.01)和疗效指数(系数=−0.10,95%CI=−0.20–−0.01,而FS-LASIK与ICL没有显著差异(系数分别为−0.02、95%CI=−0.06–0.02和系数=−0.01、95%CI=−0.10–0.09)。ICL SE在手术后12个月内保持稳定。然而,在FS-LASIK和SMILE中,与手术后6个月相比,SE在12个月时显著降低。在控制了年龄、术前SE和pCDVA后,接受FS-LASIK并在12个月时目标SE在±0.5 D内的眼睛百分比显著低于接受ICL的眼睛(OR=0.14,95%CI=0.02-0.85)。结论:对于中高度近视/近视散光的矫正,ICL似乎比SMILE和FS-LASIK效果更好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Asian Journal of Ophthalmology
Asian Journal of Ophthalmology Medicine-Ophthalmology
自引率
0.00%
发文量
0
期刊介绍: Asian Journal of OPHTHALMOLOGY is the official peer-reviewed journal of the South East Asia Glaucoma Interest Group (SEAGIG) and is indexed in EMBASE/Excerpta Medica. Asian Journal of OPHTHALMOLOGY is published quarterly (four [4] issues per year) by Scientific Communications International Limited. The journal is published on-line only and is distributed free of cost via the SEAGIG website.
期刊最新文献
Is zero incidence of postoperative endophthalmitis after cataract surgery achievable Is indiscriminate use of intracameral prophylactic antibiotics in cataract surgery appropriate Ultrasound monitoring for minocyclineinduced idiopathic intracranial hypertension Subconjunctival antibiotics: an alternative to intracameral antibiotics for endophthalmitis prophylaxis in cataract surgery Changes in practice guidelines and regulations in ophthalmology due to COVID-19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1